Loading...
Loading...
Pharmaceutical Importer Β· #5 buyer for Fluticasone Β· $1.3M import value Β· 25 shipments Β· UNITED STATES Β· DGFT Verified
CIPLA USA INC UPS SUPPLY CHAIN SOLU is the #5 importer of Fluticasone from India with $1.3M in import value and 25 verified shipments. CIPLA USA INC UPS SUPPLY CHAIN SOLU holds a 0.6% market share in Fluticasone imports based in UNITED STATES. The company sources from 1 verified supplier across 3 formulations shipped to 1 country. Overall, CIPLA USA INC UPS SUPPLY CHAIN SOLU imports 23 pharmaceutical products worth $178.7M across 14 therapeutic categories.

Verified from 25 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| CIPLA LIMITED | $1.3M | 25 | 100.0% |
CIPLA USA INC UPS SUPPLY CHAIN SOLU sources Fluticasone from 1 verified Indian supplier based on 25 customs records. The primary supplier is CIPLA LIMITED accounting for 100.0% of imports.
Buyers ranked immediately above and below #5 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 15 | MEDPRO PHARMACEUTICA PTY LIMITED | SOUTH AFRICA | $1.6M | 33 | $50.0K |
| 11 | CIPLA AUSTRALIA PTY LTD, | AUSTRALIA | $1.4M | 29 | $50.0K |
| 5 | CIPLA USA INC UPS SUPPLY CHAIN SOLU β | UNITED STATES | $1.3M | 25 | $50.0K |
| 17 | MYLAN BRASIL DISTRIBUIDORA DE MEDIC | BRAZIL | $750.0K | 15 | $50.0K |
| 9 | SANDOZ PTY LTD | AUSTRALIA | $650.0K | 13 | $50.0K |
CIPLA USA INC UPS SUPPLY CHAIN SOLU ranks #5 among 664 Fluticasone importers from India. Average shipment value of $50.0K compared to the market average of $83.7K. The closest competitors by value are MEDPRO PHARMACEUTICA PTY LIMITED and CIPLA AUSTRALIA PTY LTD,.
Destination countries from 25 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| UNITED STATES | $1.3M | 25 | 100.0% |
CIPLA USA INC UPS SUPPLY CHAIN SOLU imports Fluticasone to 1 country. The primary destination is UNITED STATES receiving 100.0% of shipments worth $1.3M.
| Formulation | Value | Shipments |
|---|---|---|
| FLUTICASONE PROPIONATE 250 MCG AND SALME | $800.0K | 16 |
| FLUTICASONE PROPIONATE 500MCG AND SALMET | $250.0K | 5 |
| FLUTICASONE PROPIONATE 100 MCG AND SALME | $200.0K | 4 |
CIPLA USA INC UPS SUPPLY CHAIN SOLU imports 3 distinct Fluticasone formulations from India. The top formulation is FLUTICASONE PROPIONATE 250 MCG AND SALME with 16 shipments worth $800.0K.
What CIPLA USA INC UPS SUPPLY CHAIN SOLU and other importers must comply with to import Fluticasone from India
U.S. Food and Drug Administration (FDA)
Abbreviated New Drug Application (ANDA) for generic drugs, requiring bioequivalence studies and compliance with 21 CFR. Indian manufacturing sites must pass FDA pre-approval inspection.
Typical timeline: 10β18 months for ANDA approval
FDA cGMP compliance (21 CFR 210/211); facility inspection by FDA prior to approval
India exported $55.6M worth of Fluticasone through 9,009 shipments from 239 suppliers to 123 countries, serving 664 buyers globally. CIPLA USA INC UPS SUPPLY CHAIN SOLU imports $1.3M of this total, accounting for 0.6% of India's Fluticasone exports with 25 shipments from UNITED STATES. This is verified from 25 customs shipment records covering 3 distinct formulations.
CIPLA USA INC UPS SUPPLY CHAIN SOLU's average Fluticasone order value is $50.0K per consignment, based on 25 shipments totaling $1.3M. CIPLA USA INC UPS SUPPLY CHAIN SOLU is based in UNITED STATES and ranks #5 among all Fluticasone importers from India by value. The company sources from 1 verified supplier in India.
CIPLA USA INC UPS SUPPLY CHAIN SOLU sources Fluticasone from 1 verified Indian supplier: CIPLA LIMITED ($1.3M, 100.0%). This is based on 25 customs records.
CIPLA USA INC UPS SUPPLY CHAIN SOLU ranks #5 among 664 Fluticasone importers from India with a 0.6% market share. The top 3 importers are MYLAN IRELAND LTD ($17.4M), APOTEX INC ($7.9M), MYLAN IRELAND LIMITED ($6.8M). CIPLA USA INC UPS SUPPLY CHAIN SOLU processed 25 shipments from UNITED STATES.
CIPLA USA INC UPS SUPPLY CHAIN SOLU also imports these respiratory products. Each links to the detailed product page.
CIPLA USA INC UPS SUPPLY CHAIN SOLU imports 23 products worth $178.7M. Beyond Fluticasone, top products include Meloxicam, Amlodipine, Diclofenac, Sertraline, Budesonide. View the complete CIPLA USA INC UPS SUPPLY CHAIN SOLU profile for full portfolio analysis.
Latest developments and market context
Detailed market intelligence for Fluticasone β including regulatory updates, trade policy changes, and competitive landscape analysis β will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Verify import regulations and drug registration requirements with the agencies above.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records β the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Access order-level details, pricing data, supplier connections, and competitive analysis for CIPLA USA INC UPS SUPPLY CHAIN SOLU's Fluticasone imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
CIPLA USA INC UPS SUPPLY CHAIN SOLU
Full Company Profile β
23 products Β· $178.7M total trade Β· 14 categories
Drug Listing with FDA; Import Alert screening; Customs entry via FDA PREDICT system
US-specific labeling per 21 CFR 201 including NDC number, lot, expiry, dosage in English
Note: Subject to FDA Import Alerts and Automatic Detention if facility has open Form 483 observations.
Regulatory information is provided for general reference based on publicly available FDA guidelines for pharmaceutical imports. Requirements may vary by specific drug formulation, dosage form, and therapeutic classification. Importers should consult directly with FDA or qualified regulatory affairs professionals for case-specific guidance.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 123+ countries, 664+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Verified from customs records
Access shipment-level records, supplier contacts, and formulation details for CIPLA USA INC UPS SUPPLY CHAIN SOLU.
Request DemoView Pricing βTrade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Fluticasone. For current order-level data, contact TransData Nexus.